Mashup Score:6
RTAnswersGynecologic Cancer – RTAnswers.org - 1 week
Mashup Score:6
Mashup Score:6
RTAnswersGynecologic Cancer – RTAnswers.org - 1 week
Mashup Score:6
Mashup Score:4
Targeted OncologyFor cervical cancer awareness month, Lauren Bollinger, MD, discusses how the increase in research in the field of cervical cancer is driving the progress...
The #cervicalcancer landscape is dramatically changing for the better as new drug therapies come into play. Taking a closer look is worthwhile, as these developments will likely impact the standard of care for years to come. #gyncsm | @TheUSONetwork https://t.co/P6aDYytrDv https://t.co/P6aDYytrDv - view on twitter
Mashup Score:3
Targeted OncologyPresentation of Endometrial Cancer and MMR Testing - 21 hours
Mashup Score:3
Dr Robert Holloway describes the presentation of a typical patient with metastatic endometrial cancer, and whether all patients receive MMR...
Robert Holloway, MD, describes the presentation of a typical patient with metastatic #endometrialcancer, and whether all patients receive #MMR testing. #gyncsm | @AdventHealth https://t.co/Pw8bqTnPEC - view on twitter
Mashup Score:2
OncLiveGenetic Analysis Helps Maximize Clinical Benefit with PARP Inhibitors in BRCA+ Ovarian Cancer - 7 days
Mashup Score:2
Saketh Guntupalli, MD, highlights data supporting PARP inhibitors as the standard-of-care frontline therapy, strategies for the management of PARP-related toxicities, and the importance of...
The use of genetic testing to identify HRD and BRCA mutations in ovarian cancer can better inform the selection of frontline maintenance therapies and improve the management of PARP inhibitor–related toxicities. @CUCancerCenter #gyncsm https://t.co/yNTXo951zm https://t.co/yNTXo951zm - view on twitter
Mashup Score:2
ascopost.comBy The ASCO Post Staff Posted: 1/18/2023 12:32:00 PM Last Updated: 1/18/2023 1:06:31 PM A specific colonization of pathogenic microbes in the reproductive tract...
Ovarian Cancer May Be Linked to Pathogenic Microbe Colonization in Reproductive Tract https://t.co/lI2LDv8lgM #gyncsm #OvarianCancer #oncology - view on twitter
Mashup Score:1
Current ActivitiesEC Fireside Chat — Current Activities - 1 week
Mashup Score:1
In partnership with Tumor Board Tuesday, this CME-certified, Twitter-based video Fireside Chat will assess safety of anti-angiogenic therapy and immune checkpoint inhibitor treatments, particularly...
💥#EndometrialCancer TKI/IO safety data & AE mgmt webinar 💥┈┈┈ w @DrMMurphy & @drteplinsky ┈┈┈🔹#CME info 👉 https://t.co/ZMWmm5EsIE 👈 @BonumCE ┈┈┈🔸Supported by edu grants from Eisai & @Merck 🔹#TumorBoardTuesday #gyncsm #OncTwitter https://t.co/ZMWmm5EsIE - view on twitter
Mashup Score:1
ascopost.comBy Matthew Stenger Posted: 1/23/2023 10:24:00 AM Last Updated: 1/23/2023 11:31:50 AM In an analysis reported in the Journal of Clinical Oncology, Vicky Makker,...
Lenvatinib and Pembrolizumab in Previously Treated Patients With Advanced Endometrial Carcinoma: Update of Study 111/KEYNOTE-146 https://t.co/x86oMEoBhq #gyncsm #endometrialcancer #oncology #immunotherapy - view on twitter
Mashup Score:1
Current ActivitiesEC Tweetorial — Current Activities - 1 week
Mashup Score:1
In partnership with Tumor Board Tuesday, this CME-certified, Tweetorial reviews the latest data related to anti-angiogenic therapies and immune checkpoint inhibitors in Endometrial Carcinoma...
2/#TumorBoardTuesday #BonumCE #OncTwitter #gyncsm #gynonc #EndometrialCancer #MedTweetorial 🆓 CME > full info➕ref list🗒️& program archive 👉https://t.co/Nytez5VA4X 🔑#CME info👇 https://t.co/Nytez5VA4X - view on twitter
Mashup Score:1
OncLiveKathleen N. Moore, MD, MS, discusses the investigation of nab-sirolimus in TSC1/2-mutated gynecologic...
Kathleen N. Moore, MD, MS, of @OUCollegeofMed, discusses the investigation of nab-sirolimus in TSC1/2-mutated gynecologic cancers. #gyncsm https://t.co/THi6HiprJ7 https://t.co/THi6HiprJ7 - view on twitter
The FDA has granted a fast track designation to DB-1303 for the treatment of patients with advanced, recurrent or metastatic endometrial cancer with HER2...
FDA Grants Fast Track Designation to DB-1303 for HER2-Overexpressed Advanced/Recurrent Endometrial Cancer #gyncsm https://t.co/My4mT8bF8m - view on twitter
Treatment for gynecologic cancers depends on several factors, including the type of cancer, its extent (stage), its location and your overall health. It is...
January is Cervical Cancer Awareness Month. According to the American Cancer Society, 115,130 women will be diagnosed with some form of gynecologic cancer this year. Learn how radiation therapy is used to treat gynecologic cancers here: https://t.co/FG1aG3pZgU #gyncsm https://t.co/FG1aG3pZgU - view on twitter